STRUCTURE THERAPEUTICS INC. - AMERICAN DEPOSITARY

27.40

07-February-25 15:45:00

15 minutes delayed

Stocks

-2.62

-8.73%

Today's range

27.28 - 30.59

ISIN

N/A

Source

NASDAQ

Structure Therapeutics Announces Positive Results from Phase 1b Clinical Study of Oral GLP-1 Receptor Agonist GSBR-1290 and Provides Program Update

29 Sep 2023 06:30:00 By Nasdaq GlobeNewswire
Structure Therapeutics Reports Second Quarter 2023 Financial Results and Recent Highlights

10 Aug 2023 15:05:01 By Nasdaq GlobeNewswire
Structure Therapeutics Appoints Ted W. Love, M.D., to Board of Directors

03 Aug 2023 16:32:00 By Nasdaq GlobeNewswire
Structure Therapeutics to Present at Jefferies Healthcare Conference

31 May 2023 15:30:00 By Nasdaq GlobeNewswire
Structure Therapeutics Initiates Phase 2a Study of Oral GLP-1 agonist GSBR-1290 for the Treatment of Type 2 Diabetes and Obesity

25 May 2023 15:30:00 By Nasdaq GlobeNewswire
Structure Therapeutics Announces Poster Presentations at the American Thoracic Society International Conference

18 May 2023 15:30:00 By Nasdaq GlobeNewswire
Structure Therapeutics Reports First Quarter 2023 Financial Results and Recent Highlights

11 May 2023 15:30:00 By Nasdaq GlobeNewswire
Structure Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Highlights

30 Mar 2023 15:30:00 By Nasdaq GlobeNewswire

<<
<
1
2
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.